Most Recent
Indian drug maker Cipla has lost a challenge to the extension of Novo Nordisk’s patent for Victoza, with a judge rejecting an argument that extensions can be granted only for active ingredients.
A group of leading partners that departed Corrs Chambers Westgarth months ago has turned up at King & Wood Mallesons, in a coup for KWM's employment practice.
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.
Crocs unit Jibbitz has sued an Australian company that has allegedly been selling knock-off versions of its shoe accessories, claiming damages for patent infringement.
Power and gas company Sumo has been ordered to pay a $10 million penalty for engaging in prohibited 'door-to-door' phone sales, the largest penalty for breaches of Victoria’s energy laws.
Ten has resolved a case by former journalist Tegan George that alleged the network's Canberra bureau had a culture that was “sexually hostile, demeaning and oppressive”.
Two High Court cases weighing key issues for class action practitioners will likely push the trial in a shareholder proceeding against the collapsed Blue Sky Alternative Investments and auditor EY to early 2026.
The Full Court has overturned a finding that singer Katy Perry infringed an Australian fashion designer's 'Katie Perry' mark, finding the designer knew of the pop star when she registered the mark.
As it fends off a suit by AstraZeneca seeking to block the sale of a cheaper version of Brilinta, generics maker Pharmacor claims a patent for the heart attack drug should not have been extended.
A judge has called out the “combative correspondence” between solicitors at Corrs Chambers and another law firm in a construction defects suit.